Skip to main content

Fundamentals of Infection Control and Strategies for the Intensive Care Unit

  • Chapter
Infectious Diseases in Critical Care

Abstract

The mission of a hospital infection control program is to ensure continuous improvement in the delivery of patient care. This is done through a structured surveillance, which reviews, analyzes, and reports healthcare-associated infection (HAI) rates. It is the overall intent of the program to identify and reduce the risk of acquiring and transmitting infections among patients, staff, physicians, other healthcare professionals and visitors to the institution. There are in essence three specific goals of a hospital infection control program. The first goal involves the protection of the patient, which is accomplished through ensuring that a low risk exists for the acquisition of a HAI. This has become a daunting exercise in the presence of a high-risk patient population coupled with an environment that fosters the development of widespread antibiotic resistance. However, there is substantial published data demonstrating that an effective infection control program results in a reduced infection rate, increased case-specific patient survival, fewer complications and a reduction in hospitalized days [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Scheckler WE, Brimhall D, Buck AS, Farr BM, et al. (1998) Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Infect Control Hosp Epidemiol 19:114–124

    Article  CAS  PubMed  Google Scholar 

  2. Jarvis WR (1996) Selected aspects of the socioeconomic impact of nosocomial infections. Infect Control Hosp Epidemiol 17:552–557

    Article  CAS  PubMed  Google Scholar 

  3. Gaynes RP (1997) Surveillance of nosocomial infections: a fundamental ingredient for quality. Infect Control Hosp Epidemiol 18:475–478

    Article  CAS  PubMed  Google Scholar 

  4. Flanders SA, Collard HR, Saint S (2006) Nosocomial pneumonia: state of the science. Am J Infect Control 54:84–93

    Article  Google Scholar 

  5. Pittet D, Tarara D, Wenzel R (1994) Nosocomial bloodstream infections in the critically ill patients. J Am Med Assoc 271:1598–1601

    Article  CAS  Google Scholar 

  6. Krzywda EA, Andris DA, Edmiston CE (1999) Catheter infections: diagnosis, etiology, treatment, and prevention. Nutr Clin Practice 14:178–190

    Article  Google Scholar 

  7. Pearson ML, Abrutyn E (1997) Reducing the risk for catheter-related infection; a new strategy. Ann Intern Med 127:294–303

    Google Scholar 

  8. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sheretz R (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections. Ann Internal Med 143:570–580

    CAS  Google Scholar 

  9. Pottinger JM, Herwaldt LA (1997) Basic surveillance — an overview. Infect Control Hosp Epidemiol 18:513–527

    Article  CAS  PubMed  Google Scholar 

  10. Gaynes RP, Solomon S (1996) Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv 22:457–467

    CAS  PubMed  Google Scholar 

  11. McKibben L, Horan T, Tokars JI, Fowler G, Cardo DM, Pearson ML, Brennan ML (2005) Guidance on public reporting of healthcare-associated infections: recommendations of the healthcare infection control practices advisory committee. Am J Infect Control 33:217–226

    Article  PubMed  Google Scholar 

  12. Hospital Infection Program, Centers for Disease Control and Prevention (2004) National nosocomial infection surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485

    Article  Google Scholar 

  13. Wenzel RP, Osterman CA, Hunting KJ, Gwaltney JM (1976) Hospital-acquired infection, I: surveillance in a university hospital. Am J Epidemiol 103:251–260

    CAS  PubMed  Google Scholar 

  14. Glenister H, Taylor L, Barlett C, Cooke M, et al. (1991) An assessment of selective surveillance methods for detecting hospital acquired infection. Am J Med 91(Suppl 3B):121S–124S

    Article  CAS  PubMed  Google Scholar 

  15. Fridkin SK, Gaynes RP (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20:303–316

    Article  CAS  PubMed  Google Scholar 

  16. Wensel RP, Edmond MB (2001) Impact of hospital-acquired bloodstream infection. Emerg Infect 7:174–177

    Article  Google Scholar 

  17. Lubelchek RJ, Weinstein RA (2006) Strategies for preventing catheter-related bloodstream infections: the role of new technologies. Crit Care Med 34:905–907

    Article  PubMed  Google Scholar 

  18. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Person ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. MMWR 51(No. RR-10):1–36

    PubMed  Google Scholar 

  19. Krzywda E, Andris D, Edmiston CE, Quebbeman EJ (1996) Hickman catheter sepsis: efficacy of antibiotic lock therapy. Infect Control Hosp Epidemiol 16:596–598

    Article  Google Scholar 

  20. Benoit JL, Carandang G, Sitrin M, et al. (1995) Intraluminal antibiotic treatment of central venous catheter infections in patients receiving nutrition at home. Clin Infect Dis 21:1286–1288

    CAS  PubMed  Google Scholar 

  21. Widmer AF (1997) Intravenous-related infections. In: Wenzel RP (ed) Prevention and control of nosocomial infections. Williams & Wilkins, Philadelphia, pp 771–805

    Google Scholar 

  22. Rubinson L, Wu AW, Haponik EF, Diette GB (2005) Why is it that internists do not follow guidelines for preventing intravascular catheter infections. Infect Control Hosp Epidemiol 26:525–533

    Article  PubMed  Google Scholar 

  23. Adams D, Quayum M, Worthington T, Lambert P, Elliott T (2005) Evaluation of a 2% chlorhexidine in 70 isopropyl alcohol skin disinfectant. J Hosp Infect 61:287–290

    Article  CAS  PubMed  Google Scholar 

  24. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S (2002) Chlorhexidine compared with povidone solution for vascular catheter site care: a meta analysis. Ann Intern Med 136:792–801

    CAS  PubMed  Google Scholar 

  25. Maki DG, Rinder M (1987) Evaluation of dressing regimens for prevention of infection with peripheral venous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. J Am Med Assoc 258:2396–2403

    Article  CAS  Google Scholar 

  26. Faubion WC, Wesley JR, Khaldi N, Silva J (1986) Total parenteral nutrition catheter sepsis: impact of the team approach. J Parenter Enteral Nutr 10:642–645

    Article  CAS  Google Scholar 

  27. Tomford JW, Hershey CO, McLaren CE, Porter DK, et al. (1984) Intravenous therapy team and peripheral venous catheter-associated complications. A prospective control study. Arch Intern Med 144:1191–1194

    Article  CAS  PubMed  Google Scholar 

  28. Danzig LE, Short L, Collins K, et al. (1995) Bloodstream infections associated with needleless intravenous infusion systems and total parenteral nutrition. J Am Med Assoc 273:1862–1864

    Article  CAS  Google Scholar 

  29. Larson EL, Cheng G, Choo JTE, Merz W (1993) In-vitro survival of skin flora in heparin locks and needleless valve infusion devices. Heart Lung 22:459–462

    CAS  PubMed  Google Scholar 

  30. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcome of healthcare-associated pneumonia: results from a large US database of culture positive pneumonia. Chest 128:3854–3862

    Article  PubMed  Google Scholar 

  31. Edmiston CE (1999) Nosocomial infections: bacterial pneumonia, In: Atlee JL (ed) Complications in anesthesia. WB Saunders, Philadelphia, pp 208–210

    Google Scholar 

  32. Rello J, Ollendorf DA, Oster G, et al. (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121

    Article  PubMed  Google Scholar 

  33. Guidelines for the management of adults with hospital-acquired ventilator-associated, and healthcare-associated pneumonia (2005) Am J Respir Crit Care 171:388–416

    Google Scholar 

  34. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention (1999) National Nosocomial Infection Surveillance (NNIS) system report, January 1990–May 1999. Am J Infect Control 27:520–532

    Article  Google Scholar 

  35. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R (2004) Guidelines for preventing healthcare-associated pneumonia. MMWR 53(RR03):1–36

    PubMed  Google Scholar 

  36. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, et al. (1986) Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 133:792–796

    CAS  PubMed  Google Scholar 

  37. Rello J, Torres A, Ricart M, Valles J, et al. (1994) Ventilator-associated pneumonia by Staphylococcus aureus. Am J Respir Crit Care Med 150:1545–1549

    CAS  PubMed  Google Scholar 

  38. Darouiche RO (1999) Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 29:1371–1377

    Article  CAS  PubMed  Google Scholar 

  39. Srinivasan A, Karchmer T, Richards A, Song X, Perl TM (2006) A prospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 27:38–43

    Article  PubMed  Google Scholar 

  40. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention (1996) Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 17:53–80

    Article  Google Scholar 

  41. Owen RC (2006) Clostridium difficile-associated disease: an emerging threat to patient safety. Pharmacotherapy 26:299–311

    Article  Google Scholar 

  42. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention (1995) Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 16:105–113

    Article  Google Scholar 

  43. Shlaes DM, Gerding DN, John JF, Craig WA, et al. (1997) Society for Healthcare Epidemiology of America and Infectious Disease Society of American Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals. Infect Control Hosp Epidemiol 18:275–291

    Article  CAS  PubMed  Google Scholar 

  44. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, McGowan JE (2002) Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 8:697–701

    PubMed  Google Scholar 

  45. Shorr AF, Combes A, Kollef MH, Chastre J (2006) Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 34:700–706

    Article  PubMed  Google Scholar 

  46. Gaynes R, Edward JR (2005) Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis 41:848–854

    Article  PubMed  Google Scholar 

  47. Edmiston CE, Seabrook GR, Hennen C (2001) The importance of beta-lactamase resistance in surgical infections. Surg Infect 2:1–10

    Article  Google Scholar 

  48. Edmiston CE (1996) Vancomycin resistance: when failure becomes an opportunity for leadership. Ann Pharmacother 30:680–682

    PubMed  Google Scholar 

  49. Healthcare Infection Control Practices Advisory Committee (2002) Guideline for hand hygiene in healthcare settings. MMWR 51(No. RR-16):1–45

    Google Scholar 

  50. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit. Arch Intern Med 166:306–312

    Article  CAS  PubMed  Google Scholar 

  51. Lai KK, Fontecchio SA (2002) Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control 30:221–225

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Edmiston, C.E., Wilson, P.J., Grahn, B.F. (2007). Fundamentals of Infection Control and Strategies for the Intensive Care Unit. In: Rello, J., Kollef, M., Díaz, E., Rodríguez, A. (eds) Infectious Diseases in Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34406-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34406-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34405-6

  • Online ISBN: 978-3-540-34406-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics